Home Drugs P2Y12 inhibitors (drug class)
Registry trials: P2Y12 inhibitors (drug class) 17 registry trials linked to P2Y12 inhibitors (drug class) with phase phase 3, of 72, newest start first. Assembled by a program from ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.
Each filter is a page of its own, so they work one at a time. Choose Whole list to start again.
Phase 3 Recruiting Planned start 2026-04-20 355 planned NCT07582835
Phase 3 Completed Started 2024-02-19 2,200 enrolled NCT06318481
Phase 3 Completed Started 2022-10-01 900 enrolled NCT05553613
Phase 3 Unknown status Started 2022-05-01 900 planned NCT06591312
Phase 3 Completed Started 2021-09-01 580 enrolled NCT06120725
Phase 3 Completed Started 2018-10-28 259 enrolled NCT03357874
Phase 3 Completed Started 2018-01-22 11,016 enrolled Results posted NCT03354429
Phase 3 Completed Started 2017-01-09 1,900 enrolled NCT02617290
Phase 3 Completed Started 2016-09 120 enrolled NCT02944123
Phase 3 Completed Started 2015-08 3,799 enrolled NCT02298088
Phase 3 Unknown status Start date 2015-03 487 planned NCT02352402
Phase 3 Completed Started 2014-02-10 19,271 enrolled Results posted NCT01991795
Phase 3 Unknown status Start date 2013-01 180 planned NCT01812330
Phase 3 Completed Started 2012-12-04 13,885 enrolled Results posted NCT01732822
Phase 3 Completed Start date 2011-07 187 enrolled NCT01505790
Phase 3 Completed Start date 2010-10 21,379 enrolled Results posted NCT01225562
Phase 3 Terminated Started 2010-05-28 4,881 enrolled Results posted NCT00991029